Skip to main content
. 2019 Jan 22;2019(1):CD012167. doi: 10.1002/14651858.CD012167.pub2

2.1. Analysis.

Comparison 2 Azelastine 4 mg/d versus placebo, Outcome 1 Secondary outcome 1. Physician‐assessed clinical signs: mean overall response rate (number of participants who responded to treatment) 2 weeks after baseline.